Skip to main content
construction release_alert
Profile editing will be unavailable for Scholars@Duke profiles from June 11-24, 2026 as manual profile data entry transitions to Elements. More information about the transition.
cancel
Journal cover image

Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.

Publication ,  Journal Article
De Luca, G; Suryapranata, H; Stone, GW; Antoniucci, D; Tcheng, JE; Neumann, F-J; Bonizzoni, E; Topol, EJ; Chiariello, M
Published in: J Am Coll Cardiol
February 7, 2006

Duke Scholars

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

February 7, 2006

Volume

47

Issue

3

Start / End Page

685 / 686

Location

United States

Related Subject Headings

  • Survival Rate
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Immunoglobulin Fab Fragments
  • Humans
  • Electrocardiography
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
De Luca, G., Suryapranata, H., Stone, G. W., Antoniucci, D., Tcheng, J. E., Neumann, F.-J., … Chiariello, M. (2006). Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol, 47(3), 685–686. https://doi.org/10.1016/j.jacc.2005.11.018
De Luca, Giuseppe, Harry Suryapranata, Gregg W. Stone, David Antoniucci, James E. Tcheng, Franz-Josef Neumann, Erminio Bonizzoni, Eric J. Topol, and Massimo Chiariello. “Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.J Am Coll Cardiol 47, no. 3 (February 7, 2006): 685–86. https://doi.org/10.1016/j.jacc.2005.11.018.
De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann F-J, Bonizzoni E, Topol EJ, Chiariello M. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol. 2006 Feb 7;47(3):685–686.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

February 7, 2006

Volume

47

Issue

3

Start / End Page

685 / 686

Location

United States

Related Subject Headings

  • Survival Rate
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Immunoglobulin Fab Fragments
  • Humans
  • Electrocardiography
  • Combined Modality Therapy